Rezolute (RZLT) Debt Ratio (2011 - 2022)

Rezolute (RZLT) reported Debt Ratio of 0.21 for Q1 2022, up 20.79% sequentially from 0.17 in Q4 2021.

Rezolute (RZLT) Debt Ratio (2011 - 2022) Analysis & Trends

Rezolute (RZLT) has 7 years of Debt Ratio data on file, last reported at 0.21 in Q1 2022.

For the quarter ending Q1 2022, Debt Ratio changed N/A year-over-year to 0.21; the trailing twelve-month figure through Mar 2022 stood at 0.21 (changed N/A YoY), and the FY2021 full-year result was 0.33, changed N/A from the prior year.
Debt Ratio climbed to 0.21 in Q1 2022, from 0.17 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 13.48 in Q4 2018 to a low of 0.17 in Q4 2021.
A 3-year average of 2.47 and a median of 0.32 in 2018 frame the typical range for Debt Ratio.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	1.41
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.11
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.05
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Rezolute	31,153.77	31,153.77	-	-

Download Data